<DOC>
	<DOCNO>NCT00239655</DOCNO>
	<brief_summary>The purpose study test MK0812 disease activity patient relapsing-remitting MS. Disease modify activity assess measurement brain lesion via MRI brain scan open label extension offer .</brief_summary>
	<brief_title>A Study Assess Effects MK0812 Disease Activity Patients With Relapsing-Remitting Multiple Sclerosis Measured Magnetic Resonance Imaging ( MRI ) ( 0812-003 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Patients must clinically definite relapsingremitting MS onset within last 10 year least 1 objective clinical exacerbation last year OR recent clinically isolated syndrome suggestive MS occur 312 month screen Patients must relatively healthy Patient primary progressive MS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>